BackgroundThe need for a blood transfusion, defined as hemoglobin < 70 g/L, is the measure forassessing the risk levels in patients with upper gastrointestinal bleeding (UGIB).However, not all patients with a low hemoglobin level have a poor prognosis.ObjectiveWe assessed the clinical predictive factors associated with poor short-term prognosisin patients with a low hemoglobin level.MethodsIn this prospective cohort study, all consecutive patients with suspected acute UGIB atTokyo Metropolitan Tama Medical Center were enrolled between 2008 and 2015. Then, weextracted those who needed a blood transfusion (hemoglobin < 70 g/L) and explored thevariables associated with all-cause mortality within 28 days after presentation.ResultsAmong 1307 patients, 311 needed a blood transfusion and 13 (4.2%) died from all causes.The presence of high-risk stigmata requiring endoscopic treatment (peptic ulcers;Forrest scores Ia, Ib and IIa; varices with current bleeding or signs of recentbleeding; and spurting or gushing bleeding or visible vessel in other diseases),diagnosed by emergency endoscopy, was a unique factor affecting mortality (odds ratio:8.47, 95% confidence interval: 1.45–160, P = 0.01). Patients withouthigh-risk stigmata neither died from UGIB nor had rebleeding, irrespective of thehemoglobin levels.ConclusionsPatients without high-risk stigmata showed a good prognosis even if they needed a bloodtransfusion. This result could facilitate triage of patients with suspected acute UGIBwho only need a blood transfusion.
United European Gastroenterology Journal – SAGE
Published: Jun 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera